Shujing Chen

452 total citations
25 papers, 285 citations indexed

About

Shujing Chen is a scholar working on Molecular Biology, Infectious Diseases and Oncology. According to data from OpenAlex, Shujing Chen has authored 25 papers receiving a total of 285 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Infectious Diseases and 4 papers in Oncology. Recurrent topics in Shujing Chen's work include COVID-19 Clinical Research Studies (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Natural product bioactivities and synthesis (3 papers). Shujing Chen is often cited by papers focused on COVID-19 Clinical Research Studies (3 papers), Traditional Chinese Medicine Analysis (3 papers) and Natural product bioactivities and synthesis (3 papers). Shujing Chen collaborates with scholars based in China, United States and Netherlands. Shujing Chen's co-authors include Jinjun Jiang, Yongfu Yu, Yanxu Chang, Dingyu Zhang, Jin Li, Kunze Du, Chunxiao Liang, Yuhong Li, Qi Wu and Zhijian Liu and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Chromatography A and Frontiers in Immunology.

In The Last Decade

Shujing Chen

22 papers receiving 278 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shujing Chen China 10 78 61 60 55 39 25 285
Huan Lu China 12 21 0.3× 28 0.5× 93 1.6× 16 0.3× 16 0.4× 23 306
Qianzhou Lv China 13 56 0.7× 54 0.9× 112 1.9× 4 0.1× 23 0.6× 41 428
Aakash Sheth United States 9 63 0.8× 66 1.1× 55 0.9× 4 0.1× 9 0.2× 50 321
Shoko Furukawa Japan 14 14 0.2× 17 0.3× 99 1.6× 31 0.6× 6 0.2× 59 575
Ai Cui China 11 17 0.2× 25 0.4× 47 0.8× 12 0.2× 4 0.1× 20 453
Weihua Dong China 9 65 0.8× 39 0.6× 87 1.4× 3 0.1× 23 0.6× 28 272
Mahmoud Morsi Egypt 12 19 0.2× 61 1.0× 39 0.7× 6 0.1× 5 0.1× 23 404
Abozer Y. Elderdery Saudi Arabia 11 30 0.4× 26 0.4× 82 1.4× 2 0.0× 20 0.5× 63 395

Countries citing papers authored by Shujing Chen

Since Specialization
Citations

This map shows the geographic impact of Shujing Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shujing Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shujing Chen more than expected).

Fields of papers citing papers by Shujing Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shujing Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shujing Chen. The network helps show where Shujing Chen may publish in the future.

Co-authorship network of co-authors of Shujing Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Shujing Chen. A scholar is included among the top collaborators of Shujing Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shujing Chen. Shujing Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Shujing, Caifang Gao, Wei Wei, et al.. (2025). A Comprehensive Review on Botany, Ethnopharmacology, Phytochemistry, Biosynthesis, Pharmacology, Toxicity, Quality Control and Metabolomics of Coptidis Rhizome. The American Journal of Chinese Medicine. 53(6). 1711–1754. 3 indexed citations
2.
Chen, Shujing, Changqing Liu, Huihui Sun, et al.. (2025). A comprehensive review of natural products in rheumatoid arthritis: therapeutic potential and mechanisms. Frontiers in Immunology. 16. 1501019–1501019.
3.
Chen, Shujing, et al.. (2025). A novel few-shot deep regression domain adaptation method with wavelet scattering attention mechanism for fault prognostics. Nondestructive Testing And Evaluation. 41(1). 233–252.
4.
Wang, Yajun, et al.. (2025). Tetrathiomolybdate alleviates bleomycin-induced pulmonary fibrosis by reducing copper concentration and suppressing EMT. European journal of medical research. 30(1). 394–394. 1 indexed citations
5.
Liu, Changqing, Shujing Chen, Huihui Sun, et al.. (2024). Columbianadin ameliorates rheumatoid arthritis by attenuating synoviocyte hyperplasia through targeted vimentin to inhibit the VAV2/Rac-1 signaling pathway. Journal of Advanced Research. 74. 609–620. 4 indexed citations
6.
Wang, Yajun, et al.. (2023). Machine learning‐based identification of cuproptosis‐related markers and immune infiltration in severe community‐acquired pneumonia. The Clinical Respiratory Journal. 17(7). 618–628. 7 indexed citations
7.
Shang, Ye, Suyi Liu, Chunxiao Liang, et al.. (2022). An Integrated Strategy of Chemical Fingerprint and Network Pharmacology for the Discovery of Efficacy-Related Q-Markers of Pheretima. International Journal of Analytical Chemistry. 2022. 1–12. 5 indexed citations
8.
Chen, Shujing, Sihua Wang, Yongfu Yu, et al.. (2021). Association between risk of venous thromboembolism and mortality in patients with COVID-19. International Journal of Infectious Diseases. 108. 543–549. 7 indexed citations
9.
Chen, Shujing, Yun Bai, Yuan Wang, et al.. (2021). Immunosuppressive effect of Columbianadin on maturation, migration, allogenic T cell stimulation and phagocytosis capacity of TNF-α induced dendritic cells. Journal of Ethnopharmacology. 285. 114918–114918. 12 indexed citations
10.
Chen, Shujing, Yuan Wang, Chunxiao Liang, et al.. (2020). Buyang Huanwu Decoction ameliorates atherosclerosis by regulating TGF-β/Smad2 pathway to promote the differentiation of regulatory T cells. Journal of Ethnopharmacology. 269. 113724–113724. 32 indexed citations
12.
Chen, Shujing, et al.. (2020). DVT incidence and risk factors in critically ill patients with COVID-19. Journal of Thrombosis and Thrombolysis. 51(1). 33–39. 68 indexed citations
13.
Chen, Shujing, Shuangqi Li, Jia‐Cheng Lu, et al.. (2020). The association between monocytic myeloid-derived suppressor cells levels and the anti-tumor efficacy of anti-PD-1 therapy in NSCLC patients. Translational Oncology. 13(12). 100865–100865. 12 indexed citations
14.
Ge, Yuanyuan, Shujing Chen, Qian Luo, et al.. (2019). The Tissue Distribution of Four Major Coumarins after Oral Administration of Angelicae Pubescentis Radix Extract to Rats Using Ultra-High-Performance Liquid Chromatography. Evidence-based Complementary and Alternative Medicine. 2019. 1–8. 9 indexed citations
15.
Ma, Wenfang, Xiaoyan Wang, Shujing Chen, et al.. (2019). A network pharmacology integrated pharmacokinetics strategy for uncovering pharmacological mechanism of compounds absorbed into the blood of Dan-Lou tablet on coronary heart disease. Journal of Ethnopharmacology. 242. 112055–112055. 42 indexed citations
17.
Sun, Fang, et al.. (2016). Minimally invasive open nephrectomy on children with multicystic dysplastic kidney. Experimental and Therapeutic Medicine. 12(6). 3575–3578. 1 indexed citations
18.
Qiu, Min, et al.. (2014). Development and evaluation of enterprising and magnanimous questionnaire. Zhonghua xingwei yixue yu naokexue zazhi. 23(2). 175–177.
19.
Wang, Liying, et al.. (2013). Study on influence factors of the implementation of enterprise patent strategy. Portland International Conference on Management of Engineering and Technology. 972–975. 1 indexed citations
20.
Wang, Yuehong, Sheng Meng, Yuanlin Song, et al.. (2009). Fluorescence optical fibre sensor provides accurate continuous oxygen detection in rabbit model with acute lung injury. Respirology. 15(1). 99–106. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026